Research
Hormonal
Bariatric surgery and pharmacotherapy (e.g., GLP-1 agonists) are indicated for many patients with obesity to achieve and maintain weight loss, especially when lifestyle interventions fail.
If lifestyle changes aren't enough, talk to your doctor about medication or surgery. These treatments target the biology of obesity and can significantly improve health conditions like diabetes and heart disease.
StrongSupportsHIGH confidence
Additional interventions, such as pharmacotherapy or bariatric surgery, are indicated for many patients and should be recommended. Treatment considerations should include assessment of comorbidities or risk factors, as many anti-obesity agents and bariatric surgeries also have beneficial effects on other weight-associated comorbidities.
Why this rating
Guidelines from AHA/ACC/TOS, Endocrine Society, and AACE support these interventions.
Source
Understanding the pathophysiologic pathways that underlie obesity and options for treatment
Rekha B. Kumar et al. · Expert Review of Endocrinology & Metabolism · 2021
narrative_reviewCited 18×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →